Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Resistance to sulphadoxine-pyrimethamine (SP) in Plasmodium falciparum parasites is associated with mutations in the dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) genes and has spread worldwide. SP remains the recommended drug for intermittent preventive treatment for malaria in pregnancy (IPTp) and information on population prevalence of the SP resistance molecular markers in pregnant women is limited. Methods: Temporal trends of SP resistance molecular markers were investigated in 489 parasite samples collected from pregnant women at delivery from three different observational studies between 1996 and 2009 in Kenya, where SP was adopted for both IPTp and case treatment policies in 1998. Using real-time polymerase chain reaction, pyrosequencing and direct sequencing, 10 single-nucleotide polymorphisms (SNPs) of SP resistance molecular markers were assayed. Results: The prevalence of quintuple mutant (dhfr N51 I/C59 R/S108 N and dhps A437 G/K540 E combined genotype) increased from 7 % in the first study (1996–2000) to 88 % in the third study (2008–2009). When further stratified by sample collection year and adoption of IPTp policy, the prevalence of the quintuple mutant increased from 2.4 % in 1998 to 44.4 % three years after IPTp policy adoption, seemingly in parallel with the increase in percentage of SP use in pregnancy. However, in the 1996–2000 study, more mutations in the combined dhfr/dhps genotype were associated with SP use during pregnancy only in univariable analysis and no associations were detected in the 2002–2008 and 2008–2009 studies. In addition, in the 2008–2009 study, 5.3 % of the parasite samples carried the dhps triple mutant (A437 G/K540 E/A581 G). There were no differences in the prevalence of SP mutant genotypes between the parasite samples from HIV + and HIV- women over time and between paired peripheral and placental samples. Conclusions: There was a significant increase in dhfr/dhps quintuple mutant and the emergence of new genotype containing dhps 581 in the parasites from pregnant women in western Kenya over 13 years. IPTp adoption and SP use in pregnancy only played a minor role in the increased drug-resistant parasites in the pregnant women over time. Most likely, other major factors, such as the high prevalence of resistant parasites selected by the use of SP for case management in large non-pregnant population, might have contributed to the temporally increased prevalence of SP resistant parasites in pregnant women. Further investigations are needed to determine the linkage between SP drug resistance markers and efficacy of IPTp-SP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study
Dellicour, S., Tatem, A. J., Guerra, C. A., Snow, R. W., & ter Kuile, F. O. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000221 · Cited by 490
O. ter Kuile, F., van Eijk, A. M., & Filler, S. J. (2007) · JAMA · doi:10.1001/jama.297.23.2603 · Cited by 355
Nzila, A. M., Mberu, E. K., Sulo, J., Dayo, H., Winstanley, P. A., Sibley, C. H., & Watkins, W. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.991-996.2000 · Cited by 232
Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174
Kayentao, K., Kodio, M., Newman, R. D., Maiga, H., Doumtabe, D., Ongoiba, A., Coulibaly, D., Keita, A. S., Maiga, B., Mungai, M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/426400 · Cited by 162 · cited 1×
“[5,13-15] and the neonatal mortality rate [16].”
Harrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir376 · Cited by 156 · cited 1×
“improve overall pregnancy outcomes [34].”
Malaria Prevention with IPTp during Pregnancy Reduces Neonatal Mortality
Menéndez, C., Bardají, A., Sigauque, B., Sanz, S., Aponte, J. J., Mabunda, S., & Alonso, P. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009438 · Cited by 135
Sridaran, S., McClintock, S. K., Syphard, L. M., Herman, K. M., Barnwell, J. W., & Udhayakumar, V. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-247 · Cited by 124 · cited 2×
“Collectively, these data confirm that the quintuple mutant, comprised of the dhfr triple mutant (Asn-108/Ile-51/Arg59) genotype and dhps double mutant (Gly-437/Glu-540) genotype, and other additional dhfr and dhps mutations are good predictors of SP treatment failure in children [25,29-31].”
BackgroundMaiga, O. M., Kayentao, K., Traore, B. T., Djimde, A., Traore, B., Diallo, M., Ongoiba, A., Doumtabe, D., Doumbo, S., Traore, M. S., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir374 · Cited by 78
Perrault, S. D., Hajek, J., Zhong, K., Owino, S. O., Sichangi, M., Smith, G., Shi, Y. P., Moore, J. M., & Kain, K. C. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.119 · Cited by 77 · cited 1×
“Details for these three observational studies have been described elsewhere ([37,38] and Ouma et al, manuscript in preparation).”
BackgroundSelf-citation
Cited by
Kayentao, K., Garner, P., Maria van Eijk, A., Naidoo, I., Roper, C., Mulokozi, A., MacArthur, J. R., Luntamo, M., Ashorn, P., Doumbo, O. K., et al. (2013) · JAMA · doi:10.1001/jama.2012.216231 · Cited by 298
Desai, M., Gutman, J., Taylor, S. M., Wiegand, R. E., Khairallah, C., Kayentao, K., Ouma, P., Coulibaly, S. O., Kalilani, L., Mace, K. E., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ881 · Cited by 174
“Methods Study Sites and Study Period The studies were conducted between 2009 and 2013 at 8 sites in 6 countries: 2 countries in West Africa (Mali [2 sites] and Burkina Faso [16]) and 4 in eastern and southern Africa (Zambia [19, 20], Malawi [2 sites] [15, 17, 21], Uganda [14], and Kenya [18]).”
InfluentialSelf-citationMcClure, E. M., Goldenberg, R. L., Dent, A. E., & Meshnick, S. R. (2013) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.12.014 · Cited by 78
Chico, R. M., Cano, J., Ariti, C., Collier, T. J., Chandramohan, D., Roper, C., & Greenwood, B. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12595 · Cited by 77
Metadata
- Authors
- Iriemenam, N. C., Shah, M., Gatei, W., van Eijk, A. M., Ayisi, J., Kariuki, S., Vanden Eng, J., Owino, S. O., Lal, A. A., Omosun, Y. O., Otieno, K., Desai, M., ter Kuile, F. O., Nahlen, B., Moore, J., Hamel, M. J., Ouma, P., Slutsker, L., & Shi, Y. P.
- Venue
- Malaria Journal
- Published
- 2012-04-27
- Volume
- 11
- Issue
- 1
- Pages
- 134-134
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2163460640
- Cited by
- 79
- References
- 12
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. https://app.cochat.ai/papers/10.1186/1475-2875-11-134
- The paper
- Iriemenam, N. C., Shah, M., Gatei, W., van Eijk, A. M., Ayisi, J., Kariuki, S., Vanden Eng, J., Owino, S. O., Lal, A. A., Omosun, Y. O., Otieno, K., Desai, M., ter Kuile, F. O., Nahlen, B., Moore, J., Hamel, M. J., Ouma, P., Slutsker, L., & Shi, Y. P. (2012). Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malaria Journal. https://doi.org/10.1186/1475-2875-11-134
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.